Skip to content
Research Article Open access CC BY 4.0

Anti Colton-A Foeto-Neonatal Haemolytic Disesase: Diagnosis; Clinical Outcome and Family Study

G. Gessoni, L. Collodel, I. Vaccara, M. Pivetta, T. Mancuso, P. Lago, A. Cattarozzi, N. Revelli, A. Barzan, P. Cavicchioli

International Blood Research & Reviews · pp. 29–37 · Published 27 Jan 2023

10.9734/ibrr/2023/v14i1299

Abstract

The authors report a case of neonatal haemolytic disease (HDN) attributable to maternal allo immunization to a high frequency antigen present on paternal red blood cells which have been identified as Colton-a (Coa). The case seemed worthy of reporting not only for the relative rarity of HDN from anti Coa but for the rigorous approach followed in the immunohaematological follow-up of pregnancy and for the diagnostic effort expended in identifying the specificity of the antibody. A family study of ascendants, collaterals and descendants was also carried out using genotyping techniques.

Anti-Coa family study genotyping HDFN

References (21)

  1. 1 The Blood Group Antigen FactsBook [DOI]
  2. 2 Guidelines for pre‐transfusion compatibility procedures in blood transfusion laboratories [DOI]
  3. 3 Hemolytic Disease of the Fetus and Newborn [DOI]
  4. 4 History and current standard of postnatal management in hemolytic disease of the fetus and newborn [DOI]
  5. 5 Hemolytic disease of the fetus and newborn: Current trends and perspectives [DOI]
  6. 6 Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility [DOI]
  7. 7 The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation. [DOI]
  8. 8 Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first‐trimester screening (CME) [DOI]
  9. 9 Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn [DOI]
  10. 10 Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation [DOI]
  11. 11 Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years [DOI]
  12. 12 Identification and management of fetal anemia due to hemolytic disease [DOI]
  13. 13 Noninvasive Prenatal Testing in Immunohematology—Clinical, Technical and Ethical Considerations [DOI]
  14. 14 Epidemiology of Rh Hemolytic Disease of the Newborn in the United States [DOI]
  15. 15 Human red cell aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens. [DOI]
  16. 16 RBC alloantibody prevalence and specificity in a Western Norwegian tertiary hospital [DOI]
  17. 17 Anti-Coa and severe haemolytic disease of the newborn.
  18. 18 A case report on non-D HDFN [DOI]
  19. 19 Linkage between the Colton blood group locus and ASSP11 on chromosome 7 [DOI]
  20. 20 Independence of Colton Blood Group [DOI]
  21. 21 Management of anti‐Coltona alloimmunisation in pregnancy: a case report [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

37

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.